How Should Perioperative Risk Be Assessed in a Patient With Cirrhosis?

Answer in brief: Surgical risk in cirrhosis should be estimated with more than MELD or Child-Pugh alone. The 2025 ACG guideline recommends individualized assessment incorporating liver-disease severity, prior decompensation, portal hypertension, frailty/nutrition, comorbidities, urgency and the specific operation. A validated cirrhosis-specific calculator such as VOCAL-Penn is often more informative than older generic approaches. Elective surgery should be preceded by optimization of ascites, encephalopathy, nutrition, alcohol use and other reversible factors, with multidisciplinary planning for higher-risk patients.

Why cirrhosis changes surgical risk

Cirrhosis affects hemodynamics, coagulation, renal perfusion, immune function, nutrition and the ability to tolerate physiologic stress. Operative risk therefore depends not only on the liver score but also on portal hypertension, prior decompensation and the magnitude and urgency of the planned procedure. Abdominal, cardiothoracic and emergency operations generally carry more risk than limited elective procedures. A patient with compensated cirrhosis and preserved function may tolerate selected operations well, while a patient with recent ascites, encephalopathy or acute kidney injury may have substantially higher risk despite a similar nominal MELD score.

Use a cirrhosis-specific risk model

The 2025 ACG guideline emphasizes validated risk prediction rather than a single threshold. VOCAL-Penn incorporates patient factors, liver-related variables and surgical category and has outperformed older MELD-, Child-Pugh- and Mayo-based approaches in several validations. Scores support, rather than replace, clinical judgment. They are most useful when translated into an absolute estimate of short-term mortality and decompensation that can be discussed with the patient and procedural team.

Look for modifiable risk before an elective procedure

Preoperative assessment should identify active decompensation, infection, kidney injury, clinically significant ascites, uncontrolled encephalopathy, severe malnutrition/frailty and untreated alcohol use disorder. Medication review should include diuretics, beta blockers, anticoagulants, sedatives and nephrotoxins. Portal hypertension should be characterized using available noninvasive, imaging and endoscopic data. Coagulation tests in cirrhosis should not be interpreted as a simple measure of bleeding tendency; prophylactic correction of an elevated INR without a specific indication is generally not a rational strategy.

When to defer or escalate

Elective surgery should be reconsidered when the patient has acute hepatitis, uncontrolled decompensation, severe acute kidney injury, active infection or other reversible instability. For major operations in advanced disease, hepatology, anesthesia and the surgical team should agree on the indication, alternatives, expected benefit, postoperative monitoring and rescue plan. In selected patients, transplant candidacy should be part of the discussion before irreversible elective surgery.

Practical clinical algorithm

Confirm that the surgery is necessary and define its urgency and procedural risk.
Characterize cirrhosis severity, prior decompensation, portal hypertension, renal function, nutrition/frailty and comorbidities.
Use a validated cirrhosis-specific calculator such as VOCAL-Penn when applicable.
Optimize ascites, encephalopathy, infection, kidney function, nutrition and alcohol use before elective surgery.
Agree on perioperative medication, fluid, hemostasis and postoperative monitoring plans with surgery/anesthesia.
For high-risk elective surgery, consider hepatology/transplant input and reasonable alternatives.

Common mistakes to avoid

Using MELD alone as the operative decision.
Assuming an elevated INR predicts bleeding risk in a simple linear fashion.
Proceeding with elective surgery during active decompensation or infection.
Ignoring frailty, sarcopenia and nutritional status.
Discussing “cirrhosis risk” without accounting for the actual operation and whether it is emergent.

Trainee takeaway

Perioperative risk is a three-part problem: the liver, the patient and the operation. A cirrhosis-specific calculator makes the discussion more quantitative, but optimization and procedure selection remain decisive.

Frequently asked questions

Is cirrhosis an absolute contraindication to surgery?

No. Risk varies widely. Selected compensated patients can undergo surgery safely when the operation is appropriate and risk is carefully assessed.

Which score is most useful?

VOCAL-Penn is widely used because it includes surgery-specific variables and has performed well in validation studies; clinical context still matters.

Should an elevated INR be corrected before surgery?

Not automatically. INR in cirrhosis does not directly quantify bleeding risk; correction should be driven by the procedure and specific hemostatic circumstances.

Relevant free books from Dr. Thomson

Guideline-Based Management in Hepatology — available as a free digital download from GIandHepatology.com.
Best Practice Guidelines in Hepatopancreaticobiliary Disorders — available as a free digital download from GIandHepatology.com.

References

1. Thomson ABR. Guideline-Based Management in Hepatology. CAPstone Academic Publishers; 2015.

2. Mahmud N, Fricker ZP, McElroy LM, et al. ACG Clinical Guideline: Perioperative Risk Assessment and Management in Patients With Cirrhosis. Am J Gastroenterol. 2025;120:1968-1984. doi:10.14309/ajg.0000000000003616.

3. Mahmud N, Fricker ZP, Hubbard RA, et al. Risk prediction models for post-operative mortality in patients with cirrhosis. Hepatology. 2021;73:204-218.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline.